skip nav
National Prevention Information Network
Search Help
Other Searches: Search Organizations | Search Materials | Search Campaign Resources | Search Funding
español
Share Share this page on Twitter Share this page on Facebook Share this page on LinkedIn View more options to share this page E-mail this page to a colleague Print this page


CDC TB Guidelines and Recommendations

With the extensive TB research, surveillance, and program support that CDC conducts each year, it’s possible that you may have missed some of CDC’s latest guidelines and recommendations on the detection, treatment, and care of TB. NPIN has consolidated the most recent guidelines below, so you can see them all in one place. These guidelines include recommendations of the Advisory Council for the Elimination of TB (ACET), and several of these documents are joint statements prepared by the CDC and the American Thoracic Society.

CDC TB Guidelines and Recommendations, by category
Featured CDC TB Guidelines and Recommendations


CDC Recommendations and Guidelines, by category

Current CDC guidelines and recommendations for the prevention, treatment, and control of TB are organized into these categories:

Control and Elimination These guidelines and recommendations address the obstacles and opportunities for controlling and eliminating TB in the United States, including the essential components of TB prevention and control programs, and the need to address TB in low-incidence areas of the United States and in communities with at-risk minority populations.
Diagnosis These diagnostic standards provide a practical guide and statement of principles for all persons involved in the care of patients with TB.  They cover transmission of mycobacterium tuberculosis, clinical manifestations of TB, diagnostic microbiology, tuberculin skin test, definitions of TB disease and latent infection, and treatment of TB and TB infection. 
HIV/AIDS These guidelines update previous CDC recommendations for the diagnosis, treatment, and prevention of TB among adults and children coinfected with HIV in the United States. 
TB in Specific Populations These guidelines address populations including correctional, elderly, homeless, and migrant farm workers. 
Infection Control Transmission of mycobacterium tuberculosis is a risk for patients and health care workers in healthcare facilities.  These guidelines recommend strategies for reducing this risk in healthcare facilities.
Laboratory These guidelines cover laboratory services and testing.
Multidrug-Resistant TB (MDR) Outbreaks of multidrug-resistant TB (MDR) pose a public health problem and require rapid attention.  These guidelines present an action plan to specifically address this problem and cover the management of persons exposed to MDR.
Genotyping These guidelines address the application of genotyping to tuberculosis prevention and control.
Testing Targeted tuberculin testing for latent tuberculosis infection (LTBI) is a strategic component of TB control that identifies persons at high risk for TB who would benefit by treatment of LTBI, if detected.  These guidelines provide new recommendations for targeted tuberculin testing and treatment regimens for LTBI.  Guidelines are also given to screening for TB and TB infection in high-risk populations.
Treatment These guidelines address treatment regimens for TB among adults, children, persons coinfected with HIV, persons exposed to MDR, and LTBI.
Vaccines These guidelines discuss the role of vaccines in TB prevention and control in the United States. Bacillus of Calmette and Guerin (BCG) is not recommended for programmatic use in the United States. Recognizing the importance of TB vaccines, the ACET recommends that public agencies and vaccine manufacturers develop a comprehensive strategy for new TB vaccine development.
All categories View a list of all categories for which the CDC has issued guidelines and recommendations for the prevention, treatment, and control of TB.


Featured CDC TB Guidelines and Recommendations

Provisional CDC Guidelines for the Use and Safety Monitoring of Bedaquiline Fumarate (Sirturo) for the Treatment of Multidrug-Resistant Tuberculosis
From CDC’s MMWR Recommendations and Reports; October 25, 2013 / 62(rr09);1-12

Availability of an Assay for Detecting Mycobacterium tuberculosis, Including Rifampin-Resistant Strains, and Considerations for Its Use — United States, 2013
From CDC’s MMWR Weekly; October 18, 2013 / 62(41);821-824





Page Last Updated: April 1, 2014

CDCNPIN.org

Contact Us
About Us
HIV Content Notice
Privacy Policy
Policies & Disclaimers
Site Index
Help Using the CDC NPIN Web Site

CDC NPIN Searches

Search Organizations
Search Materials
Search Funding Opportunities
Search Campaign Resources
Help Using the CDC NPIN Searches

CDC NPIN Resources

hivtest.cdc.gov
m.hivtest.cdc.gov
findtbresources.org
STD Awareness Microsite
findstdtest.org
AIDS Gov Logo and Link CDC Logo and Link